What is the evidence for using hydroxyurea for secondary stroke prevention?

نویسندگان

  • Jeffrey D Lebensburger
  • Michael R DeBaun
  • Alexis A Thompson
چکیده

A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Central nervous system complications and management in sickle cell disease.

With advances in brain imaging and completion of randomized clinical trials (RCTs) for primary and secondary stroke prevention, the natural history of central nervous system (CNS) complications in sickle cell disease (SCD) is evolving. In order of current prevalence, the primary CNS complications include silent cerebral infarcts (39% by 18 years), headache (both acute and chronic: 36% in childr...

متن کامل

Secondary prevention of overt strokes in sickle cell disease: therapeutic strategies and efficacy.

Overt strokes, previously one of the most common neurological complications in sickle cell disease (SCD), have become far less frequent with routine transcranial Doppler (TCD) assessment followed by regular blood transfusion therapy. Nevertheless, children and adults with SCD continue to have overt strokes, and in the foreseeable future will continue to require secondary prevention of strokes. ...

متن کامل

Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial.

In the past two decades, two landmark randomized controlled trials (RCT) have been completed among individuals with sickle cell disease (SCD), the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. The MSH trial tested the hypothesis that hydroxyurea will reduce the frequency of painful episodes for adults with hemoglobin SS who had a history of 3 or more pain...

متن کامل

Evidence-based bioactive phytoconstituents for human health and disease prevention

The term “medicinal” as applied to a plant indicates that it contains a substance or substances which modulate beneficially the physiology of sick mammals. Thousands of species of higher plants have been used by man for that purpose. Modern techniques have revealed the enormous variety and complexity of so-called secondary plant chemicals, i.e., those which do not occur in all species, but whic...

متن کامل

Evidence for Informing Health Policy Development in Low- Income Countries (LICS): Perspectives of Policy Actors in Uganda

Background Although there is a general agreement on the benefits of evidence informed health policy development given resource constraints especially in Low-Income Countries (LICs), the definition of what evidence is, and what evidence is suitable to guide decision-making is still unclear. Our study is contributing to filling this knowledge gap. We aimed to explore health policy actors’ views r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Hematology. American Society of Hematology. Education Program

دوره 2011  شماره 

صفحات  -

تاریخ انتشار 2011